Mandate

Vinge advises Axcel and Accru Partners in connection with the acquisitions of Ekonomernas Hus, Revisorernas Hus, RevisionsPartner, and Censio

Vinge has advised Axcel VII and Accru Partners in connection with the parallel acquisitions of Ekonomernas hus i Sverige AB, Ekonomernas Hus Örebro AB, Revisorernas Hus Sverige AB, RevisionsPartner Skaraborg AB and Censio Tax AB.

All firms are entrepreneur-led, local businesses with expertise in accounting, tax, audit and advisory services. After the acquisitions, Accru Partners consists of 26 independent firms within the aforementioned business areas.

Vinge’s team consisted of Christina Kokko, Desirée Hagenfeldt, Egil Svensson, Michella Lina Said, Madelene Andersson and Alexander Rüdén (M&A), Simon Söderholm and Narin Melazade (Employment), Kamyar Najmi and Sofia Haggren (Banking and Finance), Mario Saad (Commercial Agreements), Elis Allmark (IT), Rebecka Målquist (Intellectual Property), Nicklas Thorgerzon (GDPR), Agnes Pigg and Hanna Kövamees (Real Property), Jonna Bondemark and David Gavatin (Regulatory), Mia Falk and Gulestan Ali (Compliance) and Jessica Öijer (Transaction Support Coordinator).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025